The Situation on Generic Drugs of Cabozantinib in 2026

Cabozantinib is a targeted drug used to treat a variety of cancers and is widely used in renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), differentiated thyroid cancer (DTC) and pancreatic neuroendocrine tumors (pNET). As the market for original drugs matures, more and more countries and regions are beginning to produce generic drugs. The emergence of generic drugs not only reduces the cost of drug treatment, but also provides patients with more treatment options.

Currently, generic drugs of cabozantinib are already on the market in some overseas markets. For example, in countries and regions such as India, Bangladesh, and Laos, generic versions of cabozantinib have been approved and are widely used in the local drug market. Take the cabozantinib generic drug produced by Laos United Pharmaceuticals as an example. Its specification is 20mg*90 tablets, and the price per box may be less than 1,000 yuan (the price may change due to exchange rate fluctuations). This price is significantly lower than that of the original drug, allowing patients to have a more economical and accessible choice when receiving treatment.

These generic drugs have essentially the same efficacy as the original drugs and often provide similar therapeutic effects as the original drugs. However, the quality control and clinical monitoring of generic drugs may differ in different production countries and regions, so patients still need to rely on the advice of professional doctors to ensure the safety and effectiveness of treatment when choosing generic drugs.

The widespread use of generic drugs not only promotes the popularity of drugs, but also alleviates the high drug cost burden of patients in developing countries to a certain extent. With the global recognition of the therapeutic effect of cabozantinib and the gradual promotion of its generic drugs, the treatment coverage of cabozantinib is expected to be further expanded in the future.

Keyword tags: cabozantinib,Cabozantinib, generic drugs, price, efficacy, India, Bangladesh, Laos, drug accessibility, targeted therapy

Reference materials:https://www.drugs.com/mtm/cabozantinib.html